Learn More
Medchemexpress LLC KRAS G12D inhibitor 1 | 2621928-43-4 | MFCD00237621 | 98.5% | 582.64 g/mol | C33H32F2N6O2 | 5 MG

Supplier: Medchemexpress LLC HY1348115MG
KRAS G12D inhibitor 1 is a potent, selective small-molecule inhibitor of the oncogenic KRAS G12D mutant for preclinical research. It demonstrates subnanomolar biochemical potency and cellular activity and is supplied as solid material and as a DMSO stock for laboratory use.
- Potent inhibition of KRAS G12D (IC50 = 0.4 nM in biochemical assay).
- Inhibits KRAS G12D-mediated ERK phosphorylation (IC50 = 0.8 nM in cellular assay).
- Suitable for preclinical research of cancers with KRAS G12D mutations.
- Available as solid (1 mg, 5 mg, 10 mg) and 10 mM 1 mL DMSO stock.
- Molecular formula C33H32F2N6O2; molecular weight 582.64 g/mol.
- High purity (≈98.5%).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.